2 active not recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 2 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Recombinant Herpes Zoster Vaccine (RZV), MTX Discontinuation, MMF Discontinuation - Rheumatoid Arthritis, Spondylitis, Ankylosing | Phase 4 | Active not recruiting | University of Sao Paulo General Hospital | 2005 | 2023-05-23 | 2026-05-04 |
| A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis Baricitinib, Cyclophosphamide - Systemic Sclerosis | Phase 4 | Active not recruiting | Tongji Hospital | 60 | 2022-03-08 | 2026-01-27 |
Arthritis, Juvenile (1) · Arthritis, Rheumatoid (1) · Behcet Syndrome (1) · Dermatomyositis (1) · Herpes Zoster (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Sjogren's Syndrome (1) · Spondylarthritis (1) · Spondylitis, Ankylosing (1) · Systemic Vasculitis (1)
Connective Tissue Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Ankylosis (1) · Arthritis (1) · Autoimmune Diseases (1) · Axial Spondyloarthritis (1) · Bone Diseases (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Virus Infections (1) · Dry Eye Syndromes (1) · Eye Diseases (1) · Genetic Diseases, Inborn (1) · Hereditary Autoinflammatory Diseases (1)
Cyclophosphamide (1) · baricitinib (1)
Tongji Hospital (1) · University of Sao Paulo General Hospital (1)
Brazil (1) · China (1)
PMID 41679320, PMID 41932224, PMID 42261247, PMID 42294825, PMID 42843284